Journal:
:research in molecular medicine
0
zohreh hojati genetics division, biology department, faculty of sciences, university of isfahan, isfahan, iran
zeinab hallajian genetics division, biology department, faculty of sciences, university of isfahan, isfahan, iran
abolghasem esmaeili genetics division, biology department, faculty of sciences, university of isfahan, isfahan, iran
majid motovali-bashi genetics division, biology department, faculty of sciences, university of isfahan, isfahan, iran
hosein tabatabaeian genetics division, biology department, faculty of sciences, university of isfahan, isfahan, iran
background: amplification of her2 is seen in 20-30% of breast cancer cases. measurement of her2 gene amplification appears to be of vital importance in planning the treatment schedule for patients with breast carcinoma. the aim of our study was to evaluate her2 amplification status in malignant and benign breast tumors by differential pcr (dpcr). materials and methods: the genomic dna was extra...